Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report.

Blepharitis Myasthenia gravis Strabismus Tacrolimus

Journal

Case reports in ophthalmology
ISSN: 1663-2699
Titre abrégé: Case Rep Ophthalmol
Pays: Switzerland
ID NLM: 101532006

Informations de publication

Date de publication:
Historique:
received: 24 02 2020
accepted: 20 05 2020
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: epublish

Résumé

Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritation. Her examination showed crossed diplopia and alternating exotropia of 25 prism diopters, severe blepharitis, conjunctival hyperemia, corneal pannus, epithelial irregularities, and subepithelial opacities. Workup included pediatric neurologic examination, laboratory tests, imaging, and electrophysiological tests. Diagnoses of OMG and blepharitis with ocular surface disease were made. Topical treatment included eyelid hygiene, tea tree oil scrubbing, topical steroids, and tacrolimus ointment. Systemic treatment included corticosteroids, pyridostigmine, azathioprine, intravenous immunoglobulins, amitriptyline, and doxycycline. Both diseases were refractory to intensive immunosuppressive treatment and had simultaneous relapses and an intertwined course. Our hypothesis is that a shared immune mechanism may be the cause of both OMG and ocular surface disease in our patient.

Identifiants

pubmed: 32884545
doi: 10.1159/000508815
pii: cop-0011-0322
pmc: PMC7443649
doi:

Types de publication

Case Reports

Langues

eng

Pagination

322-329

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Semin Ophthalmol. 2010 May;25(3):79-83
pubmed: 20590417
Indian J Ophthalmol. 2014 Oct;62(10):985-91
pubmed: 25449931
Drugs. 2015 Jul;75(11):1177-85
pubmed: 26130187
N Engl J Med. 2016 Dec 29;375(26):2570-2581
pubmed: 28029925
Cochrane Database Syst Rev. 2017 Jan 09;1:CD007742
pubmed: 28068454
Neurol Clin. 2017 Feb;35(1):115-123
pubmed: 27886889
Cochrane Database Syst Rev. 2012 May 16;(5):CD005556
pubmed: 22592706
Clin Optom (Auckl). 2018 Jul 04;10:57-63
pubmed: 30214343
Eur J Ophthalmol. 2018 Sep;28(5):541-546
pubmed: 29554816
Muscle Nerve. 2016 Mar;53(3):363-9
pubmed: 26179124
Curr Eye Res. 2017 Nov;42(11):1440-1444
pubmed: 28922018
Neurol Clin. 2018 May;36(2):311-337
pubmed: 29655452
Korean J Ophthalmol. 2011 Feb;25(1):1-7
pubmed: 21350687
Clin Optom (Auckl). 2016 Aug 08;8:71-78
pubmed: 30214351

Auteurs

Roee Arnon (R)

Department of Ophthalmology, Assuta-Samson Medical Center, Ashdod, Israel.

Tal Yahalomi (T)

Department of Ophthalmology, Assuta-Samson Medical Center, Ashdod, Israel.

Irit Rozen-Knisbacher (I)

Department of Ophthalmology, Assuta-Samson Medical Center, Ashdod, Israel.
Ben Gurion University School of Medicine, Beer-Sheva, Israel.

Joseph Pikkel (J)

Department of Ophthalmology, Assuta-Samson Medical Center, Ashdod, Israel.
Ben Gurion University School of Medicine, Beer-Sheva, Israel.

Dina Mostovoy (D)

Department of Ophthalmology, Assuta-Samson Medical Center, Ashdod, Israel.
Ben Gurion University School of Medicine, Beer-Sheva, Israel.

Classifications MeSH